Pharma Targeting Revenue and Competitors

London, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pharma Targeting's estimated annual revenue is currently $62.5M per year.(i)
  • Pharma Targeting's estimated revenue per employee is $201,000

Employee Data

  • Pharma Targeting has 311 Employees.(i)
  • Pharma Targeting grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Pharma Targeting?

Bespoke Research House working exclusively with service providers. We get you to the right person in the right company at the right time with a need and the money and get you first to market. Our 3 Step Model gives you ideas you may not have had before and saves you time and money - time you could be spending nurturing relationships and closing business. We may not be right for everyone but we are 100% right for the right people. We are extraordinary for the right people. How is this going to change your world? Click for our 3 Step Model. www.pharmatargerting.com

keywords:N/A

N/A

Total Funding

311

Number of Employees

$62.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pharma Targeting News

2022-04-17 - Micreos Pharma announces success of its antibacterial enzyme that “selectively eliminates” pathogens

According to the pharma company, there is no pharmaceutical treatment available that specifically targets S. aureus yet. Micreos Pharmaceuticals...

2022-04-06 - Sanofi's CDMO spinoff set for next month as new group targets ...

The French pharma giant plans to list EUROAPI on Euronext Paris on May 6, the company said Friday. For Sanofi investors, 23 shares will yield one share in the...

2022-04-06 - Targeting GSK and AstraZeneca, Clovis lifts sinking Rubraca ...

But the biotech hopes a new win in a broad ovarian cancer patient population—and a possible FDA nod—will put its med in a better position alongside Big Pharma...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M31112%N/A
#2
$85.5M311-60%N/A
#3
$128.3M3118%N/A
#4
$79.7M3115%N/A
#5
$97.2M31124%N/A